“Pharma bro” Martin Shkreli is out of jail after serving a little bit greater than half of his sentence.

The U.S. Bureau of Prisons confirmed Wednesday that Shkreli, who had been serving seven-year sentence for securities fraud, has been transferred out of a federal correctional establishment and right into a “neighborhood confinement” facility.

“Group confinement means the inmate is in both dwelling confinement or a Residential Reentry Middle (RRC, or midway home),” the bureau mentioned in an emailed assertion. “Mr. Shkreli’s projected launch date from the custody of the BOP is September 14, 2022.”

The 39-year-old former hedge fund supervisor rose to infamy in 2015 after his firm Turing Prescribed drugs acquired the rights to the lifesaving drug Daraprim, then hiked the worth by more than 5,000%.

Previous to the acquisition, Daraprim, which is used to deal with AIDS, malaria and most cancers sufferers, value $13.50 per tablet. In an act critics maligned as blatant value gouging, Shkreli upped it to $750.

(That price remained till the Meals and Drug Administration approved a generic version of the remedy in 2020, ending Turing Prescribed drugs’ monopoly.)

A jury in 2017 found Shkreli guilty of defrauding traders in two hedge funds he ran by sending them pretend account statements and concealing big losses. Jury choice for Shkreli’s trial took longer than anticipated as a result of so many potential jurors showed a deep disdain for the executive.

Shkreli has been in jail since September of that yr, after he had his bail revoked for providing a $5,000 bounty on Facebook for a strand of Hillary Clinton’s hair.

Along with the seven-year sentence, Shkreli needed to forfeit $7.36 million, together with a one-of-a-kind Wu-Tang Clan album he bought for $2 million.